Study on the Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma: Not a Case-Control Study.

Puig i Sardà, SusanaSampogna, FrancescaTejera Vaquerizo, Antonio2017-05-032017-10-312016-102168-6068https://hdl.handle.net/2445/110405Comentari a l'editor2 p.application/pdfeng(c) American Medical Association, 2016OncologiaTumorsMetabolisme basalOncologyTumorsBasal metabolismStudy on the Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma: Not a Case-Control Study.info:eu-repo/semantics/article6680182017-05-03info:eu-repo/semantics/openAccess27732728